首页> 外文会议>World congress on medical physics and biomedical engineering;International congress of the IUPESM >Biology of high dose-high precision radiotherapy - experience from brachytherapy of cervix cancer
【24h】

Biology of high dose-high precision radiotherapy - experience from brachytherapy of cervix cancer

机译:高剂量高精度放射疗法的生物学-子宫颈癌近距离放射治疗的经验

获取原文

摘要

Brachytherapy treatments deliver high doses in only few fractions to target volumes and healthy tissues. These high dose values to target cells might be the reason for very successful brachytherapy concepts. With the integration of 3D based treatment planning into brachytherapy the spatial dose distribution in relation to topography can be investigated and taken into account during treatment plan optimization. An analysis of cervix cancer patients treated at the Department of Radiotherapy, Medical University of Vienna, with intracavita-ry brachytherapy for cervix cancer illustrate dose and volume relations focused to high dose regions. In particular, a D_(2CC) of the rectum or sigmoid >75 Gy EQD2 was associated with a significantly higher incidence of late toxicity compared to a Pj,.,. ≥75 Gy (EQD2). No clear cut off point for bladder late effects could be demonstrated. Clinically, the dose D_(2CC) ≤90 Gy EQD2 can be recommended for clinical use to minimize side effects for bladder. The current clinical experiences in cervix cancer brachytherapy are based on forward planning. The integration of DVH parameters for treatment planning of image guided brachytherapy results in the wish to include inverse planning optimization concepts. Other current research activities aim at non-rigid image registration and voxel tracing in order to refine existing radiobiological knowledge and data, respectively, on dose volume relations for targets and organs at risk.
机译:近距离放射疗法仅将极少量的高剂量剂量输送至目标体积和健康组织。这些对靶细胞的高剂量值可能是非常成功的近距离放射治疗概念的原因。通过将基于3D的治疗计划集成到近距离放射疗法中,可以在优化治疗计划时调查并考虑与地形有关的空间剂量分布。在维也纳医科大学放射治疗科接受腔内近距离放射治疗的子宫颈癌患者的分析表明,子宫颈癌的剂量和体积关系集中在高剂量区域。特别地,与Pj相比,直肠的D_(2CC)或乙状结肠> 75Gy EQD2与晚期毒性的发生率显着相关。 ≥75 Gy(EQD2)。尚无明确的膀胱迟发反应临界点。临床上,建议将D_(2CC)≤90Gy EQD2剂量用于临床,以最大程度地减少膀胱的副作用。子宫颈癌近距离治疗的当前临床经验是基于前瞻性计划的。 DVH参数的集成用于图像引导的近距离放射治疗的治疗计划导致希望包括反向计划优化概念。当前的其他其他研究活动的目标是非刚性图像配准和体素追踪,以分别完善现有放射生物学知识和数据,以了解处于危险中的靶标和器官的剂量-体积关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号